Given that the potential risk of withdrawal phenomena and rebound phenomena is greater just after abrupt discontinuation of therapy, it is recommended the dosage be lowered slowly. Decreases in clearance and protein binding, and will increase in quantity of distribution and 50 %-lifetime are already noted in people with cirrhosis. https://arthuro863pxc8.blog2freedom.com/profile